Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19.
Amal A AbbasAsma S AlgahmdiSonia MezghaniMourad Ben AyedAhmed M AlamoriGhazi A AlghamdiWail BajhmomHanan WajeehSalma S AlmutairiWafaa M RadwanPublished in: Journal of immunology research (2022)
The study findings indicate that SAA can be used as a sensitive indicator to assess the degree of disease severity and survival outcomes of COVID-19 patients.